British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary.
Williams
Bryan
B
Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, Leicester. bw17@le.ac.uk
Poulter
Neil R
NR
Brown
Morris J
MJ
Davis
Mark
M
McInnes
Gordon T
GT
Potter
John F
JF
Sever
Peter S
PS
Thom
Simon McG
SM
D000465:Algorithms; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001795:Blood Pressure Determination / Q000379:methods; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000517:prevention & control / Q000628:therapy*; D008019:Life Style; D008487:Medical History Taking / Q000379:methods; D010808:Physical Examination / Q000379:methods; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment
D000959:Antihypertensive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin